Clinical Trial Update: A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure. [Phase 2]

View source ↗

Summary

A Phase IIb trial sponsored by AstraZeneca is evaluating dapagliflozin in combination with Baxdrostat versus Baxdrostat alone for reducing albuminuria in adults…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypertension

Drugs mentioned

• Baxdrostat (Baxdrostat)
• FARXIGA (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Kidney Disease and Hypertension | Phase 2 | Status: RECRUITING